BillionToOne is trading 10% higher at $125.98 on an unattributed trading move.
- No clear company-specific announcement or event dated September 24, 2026 explains the gain; the company’s investor-relations releases show no new announcement for that date.
- The broader biotech sector is down, so sector weakness does not explain BillionToOne’s move in the opposite direction.